Stock A302440 SK BIOSCIENCE CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar SK bioscience Co.,Ltd.

Equities

A302440

KR7302440003

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 29/04/2024 am IST 		5-day change 1st Jan Change
58,800 KRW +2.44% Intraday chart for SK bioscience Co.,Ltd. +0.51% -18.33%
28/03 SK Bioscience Signs Deal with Sanofi for Five Vaccine Types MT
07/03 SK Bioscience Breaks Ground on Manufacturing Facility Expansion for Extending Product Pipeline CI

Chart calendar SK bioscience Co.,Ltd.

2.YKzqsUAlzyydRPX63_F-cKXQuQTQV8Y_qVWMwUc8gT4.C_qP_CMUvWrvEMHPkrw6R-y2yEyfA4t8_SH2gxgNuGkH3Ljjc0j_GtR2mg~af4484ec97be7f7acba1384f64cb5384

Upcoming events on SK bioscience Co.,Ltd.

02/05/2024 Q1 2024 Earnings Release
02/05/2024 12:30 pm Q1 2024 Earnings Call
26/07/2024 Q2 2024 Earnings Release (Projected)
28/10/2024 Q3 2024 Earnings Release (Projected)
25/03/2025 Q4 2024 Earnings Release (Projected)
09/05/2025 Q1 2025 Earnings Release (Projected)

Past events on SK bioscience Co.,Ltd.

06/02/2024 Investor Meeting
05/02/2024 Investor Meeting
02/02/2024 06:30 am Investor Meeting
01/02/2024 12:30 pm Q4 2023 Earnings Call
01/02/2024 Q4 2023 Earnings Release
01/11/2023 Investor Meeting - Day - 6
31/10/2023 Investor Meeting - Day - 5
30/10/2023 Investor Meeting - Day - 4
29/10/2023 Investor Meeting - Day - 3
28/10/2023 Investor Meeting - Day - 2
27/10/2023 06:30 am Investor Meeting - Day - 1
26/10/2023 12:30 pm Q3 2023 Earnings Call
26/10/2023 Q3 2023 Earnings Release
31/07/2023 06:30 am Investor Meeting
28/07/2023 01:00 pm Q2 2023 Earnings Call
28/07/2023 Q2 2023 Earnings Release
28/04/2023 06:30 am Q1 2023 Earnings Call
27/04/2023 10:30 am Investor Meeting
27/04/2023 10:30 am Analyst Meeting - NH Investment & Securities
27/04/2023 Q1 2023 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Billions KRW		Released
Forecast
Spread 		183


226
204
10.81%		929
1 016
-8.55%		457
512
-10.82%		370
338
9.16%
246

EBITDA
Billions KRW		Released
Forecast
Spread 		0,00


0,00
0,00
- 		493
498
-0.93%		142
198
-28.24%		0,00
24,7
-
-8,62

EBIT
Billions KRW		Released
Forecast
Spread 		0,00


37,7
25,4
48.47%		474
482
-1.59%		115
178
-35.31%		-12,0
-9,31
-28.82%
-68,6

Earnings before Tax (EBT)
Billions KRW		Released
Forecast
Spread 		0,00


0,00
0,00
- 		471
482
-2.16%		142
183
-22.62%		7,33
-6,90
206.18%
-38,4

Net income
Billions KRW		Released
Forecast
Spread 		0,00


0,00
0,00
- 		355
385
-7.84%		122
150
-18.46%		22,3
10,2
119.59%
-38,7

EPS
KRW		Released
Forecast
Spread 		6 933


0,00
0,00
- 		4 810
5 162
-6.82%		1 590
1 958
-18.79%		0,00
133
-
-504

Announcement Date30/03/2023/03/2107/02/2208/02/2301/02/24-

Quarterly results

Fiscal PeriodDecember 2021 S1 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Billions KRW		Released
Forecast
Spread 		257


451
554
-18.59%		87,1
150
-41.83%		138
140
-1.42%		91,1
191
-52.4%		140
191
-26.56%		20,6
45,6
-54.8%		26,5
25,8
2.76%		232
131
77.17%		90,6
65,7
37.85%
46,6


54,2


89,0


67,0

EBITDA
Billions KRW		Released
Forecast
Spread








67,6
70,6
-4.21%


16,6
45,8
-63.84%		-20,9
17,3
-220.92%




















EBIT
Billions KRW		Released
Forecast
Spread


254
263
-3.4%		23,8
64,3
-63.04%		61,2
60,4
1.33%		21,4
85,5
-75.01%		8,71
70,3
-87.6%		-29,2
6,80
-529.25%		-35,3
-26,4
-33.58%		60,9
5,23
1064.4%		-8,43
-6,58
-28.17%
-18,6


-18,4


-1,25


-6,40

Earnings before Tax (EBT)
Billions KRW		Released
Forecast
Spread


252
257
-2.15%		32,8
29,9
9.68%		55,3
63,3
-12.53%		23,2
58,7
-60.49%		30,5
66,6
-54.25%		-25,7
4,75
-640.32%		-29,2
-22,4
-30.4%		58,6
9,43
521.45%		3,61
-16,9
121.33%
-17,3


-18,4


-1,00


-4,70

Net income
Billions KRW		Released
Forecast
Spread


184
217
-15.11%		27,8
20,0
39.03%		46,1
47,6
-3.06%		20,8
59,7
-65.22%		27,7
49,6
-44.03%		-14,3
4,73
-401.44%		-16,0
-20,6
22.51%		48,4
-21,7
323%		4,17
-14,0
129.86%
-13,2


-14,0


-0,70


-3,60

EPS
KRW		Released
Forecast
Spread 		1 342









































Announcement Date12/08/2107/02/2229/04/2229/07/2231/10/2208/02/2327/04/2328/07/2326/10/2301/02/24----

Upcoming sector events for SK bioscience Co.,Ltd.

Today 04:30 pm INCYTE CORPORATION: Q1 2024 Earnings Release
02/05/2024 BRIDGEBIO PHARMA, INC.: Q1 2024 Earnings Release (Projected)
02/05/2024 TWIST BIOSCIENCE CORPORATION: Q2 2024 Earnings Release
02/05/2024 SK BIOSCIENCE CO.,LTD.: Q1 2024 Earnings Release
06/05/2024 04:30 pm AXSOME THERAPEUTICS, INC.: Q1 2024 Earnings Release
07/05/2024 BIOTEST AG: Q1 2024 Earnings Release
07/05/2024 AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected)
07/05/2024 REVANCE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
07/05/2024 APELLIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
07/05/2024 11:30 am BIOGAIA AB: Q1 2024 Earnings Release
More events

Past sector events for SK bioscience Co.,Ltd.

Today SHANGHAI RAAS BLOOD PRODUCTS CO., LTD.: Q1 2024 Earnings Release
Today SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q4 2023 Earnings Release
Today SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q1 2024 Earnings Release
Today BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED: Q4 2023 Earnings Release
29/04/2024 HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
29/04/2024 SHANGHAI OPM BIOSCIENCES CO., LTD.: Q4 2023 Earnings Release
29/04/2024 CANSINO BIOLOGICS INC.: Q1 2024 Earnings Release
29/04/2024 SHANGHAI JUNSHI BIOSCIENCES CO., LTD.: Q1 2024 Earnings Release
29/04/2024 SINOVAC BIOTECH LTD.: Q4 2023 Earnings Release (Projected)
27/04/2024 PACIFIC SHUANGLIN BIO-PHARMACY CO., LTD: Q4 2023 Earnings Release

Net sales - Quarter - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. A302440 Stock
  4. Calendar SK bioscience Co.,Ltd.